C.B. Fleet Voluntarily Recalls Its Fleet(R) Phospho-soda(R) Products After FDA Safety Alert (Medical News Today)
Following the issuance of FDA's Safety Alert on Thursday stating that oral sodium phosphates bowel cleansing solutions should be available by prescription only, C.B. Fleet Company immediately announced a voluntary recall of their over-the-counter products Fleet Phospho-soda and Fleet Phospho-soda EZ-Prep Bowel Cleansing System.

Schering Plough Announces FDA Approval Of PEGINTRON(TM) And REBETOL(R) Combination Therapy For Treating Pediatric ... (Medical News Today)
Schering-Plough Corporation (NYSE: SGP) announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval to PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) combination therapy for use in previously untreated patients 3 years of age and older with chronic hepatitis C.

Ivivi Technologies Receives FDA 510(k) Clearance for its Latest Generation SofPulse, Roma3 and Torino II ... (GlobeNewswire via Yahoo! Finance)
MONTVALE, N.J., Dec. 15, 2008 -- Ivivi Technologies, Inc. , a leader in non-invasive, electrotherapy systems, today announced that it received U.S. Food and Drug Administration 510 Clearance for the Company's currently marketed targeted pulsed electromagnetic field (tPEMF) therapeutic products.